Palliare

What Palliare does

Palliare is a privately funded medical device company founded in 2018 as a spin-out from Crospon (a gastro-diagnostic company acquired by Medtronic in 2017). The company designs and manufactures advanced insufflation and smoke evacuation systems for minimally invasive surgery, including laparoscopic, endoscopic, colorectal, and robotic procedures. Its flagship product, the EVA15 Insufflator, is an FDA 510(k)-cleared CO2 insufflator with integrated smoke evacuation featuring intelligent leak-tolerant constant pressure insufflation (7-15mmHg) and a ULPA activated carbon filter (99.9997% efficiency at 0.04 micron). The portfolio also includes the EVA5 Continuous-Flow CO2 Insufflator for GI endoscopy and the EndoTrap smoke evacuation device.

Palliare operates a direct enterprise field sales model targeting hospitals, ambulatory surgical centers, and surgical specialists (general surgeons, colorectal surgeons, bariatric surgeons, and gastroenterologists). Products are sold through direct contact with Palliare representatives with no publicly disclosed pricing. The company is incorporated in Ireland (Palliare Ltd., VAT IE3530276FH) with operations in Galway, Ireland (international headquarters, managed by Caroline Sherlock) and Oceanside, CA (US office). Leadership is led by CEO John O'Dea (30 years medtech experience, 18 US patents, Crospon co-founder) and includes board members representing Medtronic's GI Operating Unit and Seroba Life Sciences (Series A lead investor). The company has secured FDA 510(k) clearances, MDSAP certification, and EMC certification, and won the Emerging Medtech Company of the Year award at the 2025 Irish Medtech Awards.

Name

Palliare

Legal name

Palliare Ltd.

Website

https://palliare.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

Palliare is a privately funded medical device company that designs and manufactures advanced CO2 insufflation and surgical smoke evacuation systems (EVA15 Insufflator, EVA5 Insufflator) for hospitals and surgical centers performing laparoscopic, endoscopic, colorectal, and robotic procedures.

Ownership category

akta.pro rank

Product category

Surgical Insufflation and Smoke Evacuation Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)

Keywords

• Surgical smoke evacuation
• Insufflation systems
• Laparoscopic surgery devices
• Endoscopic insufflation
• Minimally invasive surgery

Headquarters

HQ city

Oceanside

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of insufflation and smoke evacuation medical devices (EVA15 Insufflator, EVA5 Insufflator, LAP-100 tubing, EndoTrap device) to hospitals, surgical centers, and healthcare providers for use in laparoscopic, endoscopic, colorectal and robotic surgery procedures.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Palliare designs, manufactures and sells medical devices for insufflation and surgical smoke evacuation in minimally invasive surgery. Its flagship EVA15 Insufflator delivers intelligent leak-tolerant constant pressure insufflation with integrated pedal-activated ULPA smoke evacuation for laparoscopic, robotic and endoscopic procedures; the EVA5 provides continuous-flow CO2 insufflation for advanced and general GI endoscopy; and the EndoTrap serves as a smoke evacuation accessory for laparoscopy solutions.

Product overview

Palliare offers a focused portfolio of medical devices centered on insufflation and smoke evacuation technology for minimally invasive surgery. The core products are the EVA15 advanced CO2 insufflator (flagship device with intelligent pressure control and smoke evacuation) and the EVA5 continuous-flow CO2 insufflator (for endoscopy procedures). The EVA15 serves laparoscopic, robotic, and endoscopic surgery applications, while the EVA5 targets general and advanced GI endoscopy. Both products feature proprietary pressure management and smoke filtration capabilities. The company also provides the EndoTrap device as part of its laparoscopy solutions. All products are designed to create safer operating environments by managing surgical smoke and maintaining optimal insufflation pressure.

Differentiator

Problem solved

Functional benefit

Products and services

• EVA15 Insufflator Advanced CO2 insufflator with integrated pedal-activated smoke evacuation for laparoscopic, robotic, colorectal and endoscopic surgery. Provides intelligent leak-tolerant constant pressure (7-15mmHg), dual insufflation modes (standard and continuous pressure), Physician Activated Bilevel Insufflation (PABI) via footswitch, ULPA-grade activated carbon filtration (99.9997% efficiency at 0.04 micron) and controlled end-of-case desufflation to 1mmHg. FDA 510(k) cleared for endoscopic and laparoscopic surgery.
• EVA5 Continuous-Flow CO2 Insufflator Continuous-flow CO2 insufflator designed for advanced and general GI endoscopy. Connects to endoscope water bottles and provides CO2 during manual insufflation with four pre-set flow rates ranging from 0.8 to 3.6 liters per minute; the 0.8 L/min ultra-low setting supports advanced procedures such as POEM.
• EndoTrap Device Smoke evacuation accessory for Palliare's laparoscopy solutions, designed to remove surgical smoke contaminants during procedures.

Quantifiable outcome

• ULPA filter provides 99.9997% efficiency at 0.04 micron for surgical smoke evacuation
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Regional players

• CooperSurgical: CooperSurgical is the women's health and minimally invasive surgery arm of CooperCompanies, supplying hysteroscopic and laparoscopic instruments including insufflation consumables. It overlaps with Palliare's laparoscopic use cases, particularly in OB/GYN-focused ambulatory surgery centers in the US market.

Direct peers

• Buffalo Filter (Filtration Group): World leader in surgical smoke evacuation systems prior to its acquisition by Filtration Group in 2019. Former CEO Samantha Bonano now sits on Palliare's board, and the company's core focus on smoke evacuation in the OR directly mirrors Palliare's integrated smoke-evacuation feature within EVA15.
• CONMED: CONMED is a global medical device company with a dedicated surgical smoke evacuation portfolio (e.g., Buffalo Filter-branded offerings and CONMED smoke evacuation pencils/filters) that competes head-to-head with Palliare's ULPA-integrated smoke evacuation in laparoscopic and endoscopic ORs.

Broad incumbents

• Stryker: Stryker is a broad surgical and capital equipment incumbent with insufflation capability (via legacy Smiths Medical / now part of PneumoClear-Insufflator lines) and integrated OR offerings. It competes for the same hospital capital budgets and surgical smoke management RFPs.
• Olympus Corporation: Olympus is a dominant endoscopy and insufflator manufacturer (e.g., UHI-4 insufflator family) serving the same GI/laparoscopic surgeon customer base. Olympus sells complete endoscopy towers with bundled insufflation, representing both a competitor and a potential OEM or distributor partner for Palliare's EVA5 and EVA15.
• Karl Storz: Karl Storz is a leading manufacturer of endoscopes, instruments, and insufflators (e.g., ENDOMAT, Thermoflator) for minimally invasive surgery. It competes directly with Palliare in laparoscopic insufflation and serves the same hospital procurement ecosystem via integrated OR solutions.
• Medtronic: Medtronic is a global medtech incumbent with a significant GI and surgical portfolio (including the assets acquired from Crospon, Palliare's parent company). Medtronic manufactures insufflation equipment through its GI/surgical franchises and could either compete with or seek to acquire Palliare's differentiated insufflation IP.
• STERIS: STERIS provides sterilization, surgical equipment, and OR integration including smoke evacuation and insufflation solutions for hospitals. Its installed base in ORs makes it a direct overlap with Palliare's customer environment, particularly around surgical smoke safety mandates.

Emerging players

• BOWA-electronic: BOWA is a German manufacturer of electrosurgery and smoke evacuation devices (e.g., ESSENT smoke evacuator) that competes in the surgical smoke evacuation category, often as a more nimble specialist compared with the broad incumbents.
• Erbe Elektromedizin: Erbe is a specialist in electrosurgery, plasma surgery, and surgical smoke evacuation (e.g., IES 2 smoke evacuator), competing in overlapping use cases around smoke management in laparoscopic and endoscopic procedures, with strong presence in European ORs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/Palliare_Eva

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Palliare